UNII FU77B4U5Z0

USTEKINUMAB

UNII Information

Unique Ingredient Identifier: FU77B4U5Z0
The Unique Ingredient Identifier (UNII) is a unique alphanumeric code assigned to a specific substance or ingredient by the FDA (Food and Drug Administration). UNII codes are non-proprietary, free, unique, unambiguous and nonsemantic. Each UNII code consists of 10 characters with both letters and numbers. The first two characters represent the source of the substance while the remaining eight characters represent the specific substance. UNII codes are primarily used to identify and track substances in several drug databases and regulatory documents related to drugs, biologics, and medical devices.
Preferred Substance Name: USTEKINUMAB
The Preferred Substance Name (PSN) is the official or preferred name of a substance or ingredient. The preferred name provides a standardized and consistent name for each substance is used in the UNII code system. The preferred name may differ from other names also commonly used to refer the same substance. The PSN is usually the name used by regulatory agencies like the FDA.
Registry Number: 815610-63-0
The Registry Number is the unique numerical identifiers assigned to a substance or ingredient by the Chemical Abstracts Service (CAS). The CAS registry number is a used and recognized standard identifier by many industries and regulatory agencies. The Registry Number facilitates cross-referencing substances between different databases that may use different naming conventions or identifiers.
NCI Thesaurus Concept Code: C84237
The NCI Thesaurus give reference terminology for many systems. The code includes vocabulary for clinical care, translational research, basic research, public information and administrative activities.
UNII to RxNorm Crosswalk: 847083 (RXCUI)
The RxNorm Ingredient Concept Code is the numeric code assigned to a specific substance or ingredient by the National Library of Medicine's RxNorm system. By including the RxNorm code in the UNII code system it is possible to crossover UNII codes to RxNom.
INN ID: 8954
Sequential number assigned by World Health Organization's International Nonproprietary Name (INN).
Ingredient Type: INGREDIENT SUBSTANCE
Substance Type: 90e0f0c9-41fc-4e7e-adcb-b1e22c6dcc40
The International Organization for Standardization - ISO 11238 substance type is used as a data element in the UNII code system to provide additional information about the type of substance being identified.

UNII Synonyms and Mappings

The following synonyms and mappings provide alternative ways to refer to the same substance or ingredient. Synonyms may include different names or spellings, alternate chemical names, trade names, or other common names.

  • ABP654 - Code
  • ABP-654 - Code
  • CNTO 1275 - Code
  • CNTO-1275 - Code
  • FYB202 - Code
  • FYB-202 - Code
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 12 P40 SUBUNIT) (HUMAN MONOCLONAL CNTO 1275 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CNTO 1275 .KAPPA.-CHAIN, DIMER - Common Name
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN-12 SUBUNIT BETA (IL-12B, CLMF P40, NKSF2)) (HUMAN MONOCLONAL CNTO 1275 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CNTO 1275 .KAPPA.-CHAIN, DIMER - Common Name
  • IMULDOSA - Brand/Trade Name
  • OTULFI - Brand/Trade Name
  • PYZCHIVA - Brand/Trade Name
  • SELARSDI - Brand/Trade Name
  • STELARA - Brand/Trade Name
  • STEQEYMA - Brand/Trade Name
  • TT-20 - Code
  • USTEKINUMAB - Name identified as having official status
  • USTEKINUMAB [EMA EPAR] - Common Name
  • USTEKINUMAB [INN] - Common Name
  • USTEKINUMAB [JAN] - Common Name
  • USTEKINUMAB [MART.] - Common Name
  • USTEKINUMAB [MI] - Common Name
  • USTEKINUMAB [PURPLE BOOK CDER] - Common Name
  • USTEKINUMAB [USAN] - Common Name
  • USTEKINUMAB [VANDF] - Common Name
  • USTEKINUMAB [WHO-DD] - Common Name
  • USTEKINUMAB-AAUZ - Name identified as having official status
  • USTEKINUMAB-AEKN - Name identified as having official status
  • USTEKINUMAB-AUUB - Name identified as having official status
  • USTEKINUMAB-KFCE - Name identified as having official status
  • USTEKINUMAB-SRLF - Name identified as having official status
  • USTEKINUMAB-STBA - Name identified as having official status
  • USTEKINUMAB-TTWE - Name identified as having official status
  • WEZLANA - Brand/Trade Name
  • YESINTEK - Brand/Trade Name

UNII Resources

Common Chemistry
CAS Common Chemistry is an open community resource of the American Chemical Society for accessing chemical information. The chemical information in the CAS database is curated by expert scientists and includes information of common and frequently regulated chemicals and information applicable to high school and undergraduate chemistry classes.
Inxight Drugs
The National Center for Advancing Translational Sciences (NCATS) Inxight Drugs database has a comprehensive drug development information. The NCATS Inxight Drugs includes manually curated data provided by private companies and FDA. The database has marketing and regulatory status information, rigorous drug ingredient definitions, biological activity, clinical use, etc.
DailyMed Regulated Products
The National Library of Medicine DailyMed is a searchable database that includes the most recent product labeling information submitted to the FDA by private companies.
NCATS GSRS Full Record
The Global Substance Registration System (GSRS) was designed to facilitate global monitoring of human and animal medicinal, food, tobacco, and cosmetic products. GSRS includes unique substance identifiers consistent with the ISO 11238 standard.
NCI Thesaurus
NCI Thesaurus (NCIt) by the National Cancer Institute provides reference terminology for clinical care, translational and basic research, and public information and administrative activities.

UNII Crossover to NDC Codes

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
51759-505Proprietary Name: Selarsdi Ustekinumab-aeknInjection, SolutionSubcutaneousTeva Pharmaceuticals Usa, Inc.ACTIVE
51759-607Proprietary Name: Selarsdi Ustekinumab-aeknInjection, SolutionSubcutaneousTeva Pharmaceuticals Usa, Inc.ACTIVE
51759-708Proprietary Name: Selarsdi Ustekinumab-aeknInjection, SolutionIntravenousTeva Pharmaceuticals Usa, Inc.ACTIVE
57894-054Proprietary Name: Stelara UstekinumabSolutionIntravenousJanssen Biotech, Inc.ACTIVE
57894-060Proprietary Name: Stelara UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-061Proprietary Name: Stelara UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
61314-651Proprietary Name: Pyzchiva Ustekinumab-ttweInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-652Proprietary Name: Pyzchiva Ustekinumab-ttweInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-654Proprietary Name: Pyzchiva Ustekinumab-ttweInjection, SolutionIntravenousSandoz IncACTIVE
65219-824Proprietary Name: Otulfi Ustekinumab-aauzInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-826Proprietary Name: Otulfi Ustekinumab-aauzInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-828Proprietary Name: Otulfi Ustekinumab-aauzSolutionIntravenousFresenius Kabi Usa, LlcACTIVE
72606-027Proprietary Name: Steqeyma Ustekinumab-stbaInjection, SolutionSubcutaneousCelltrion Usa Inc.ACTIVE
72606-028Proprietary Name: Steqeyma Ustekinumab-stbaInjection, SolutionSubcutaneousCelltrion Usa Inc.ACTIVE
72606-029Proprietary Name: Steqeyma Ustekinumab-stbaInjection, SolutionIntravenousCelltrion Usa Inc.ACTIVE
83257-023Proprietary Name: Yesintek UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-024Proprietary Name: Yesintek UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-025Proprietary Name: Yesintek UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-026Proprietary Name: Yesintek UstekinumabSolutionIntravenousBiocon Biologics Inc.ACTIVE
84612-055Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-066Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionIntravenousOptum Health Solutions (ireland) LimitedACTIVE
84612-076Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-089Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-855Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-876Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE
84612-889Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousOptum Health Solutions (ireland) LimitedACTIVE